Safety and efficacy of male urethral slings for management of persistent stress urinary incontinence after holmium laser enucleation of the prostate. Issue 4 (8th June 2020)

• Record Type: Journal Article
• Authors: Kleinguetl, Colin; Virani, Shohaib; Bird, Erin T.; El Tayeb, Marawan M.
• Is Part Of: Proceedings. Volume 33:Issue 4(2020)
• Page Start: 554
• Page End: 556
• Publication Date: 2020-06-08
• Subjects: Artificial urethral sphincter -- benign prostatic hyperplasia -- HoLEP -- holmium laser enucleation of the prostate -- midurethral sling -- stress urinary incontinence; Medicine -- Periodicals; Medicine; Medicine -- Periodicals; Periodicals; Electronic journals; 616.005
• DOI: 10.1080/08998280.2020.1778976
• Languages: English
• ISSNs: 0899-8280

Abstract

Abstract: Holmium laser enucleation of the prostate gland (HoLEP) is an alternative to the traditional transurethral resection of the prostate, especially for large-volume prostates. One complication is urinary incontinence, which is usually stress urinary incontinence (SUI). Little data exist on surgical interventions for SUI after HoLEP. This retrospective case series examined the safety and possible efficacy of a midurethral sling (MUS) following HoLEP. Between January 2016 and February 2019, 610 HoLEPs were performed at our institution. Three (0.5%) had persistent, overly bothersome symptoms of SUI. All three underwent MUS placement with a transobturator AdVance ® male sling after failed pelvic floor rehabilitation. The degree of SUI was evaluated by pad use pre-HoLEP, post-HoLEP, and post-MUS placement. Surgical times for HoLEP and MUS were evaluated. No patients were using pads for incontinence before HoLEP. The average pad use was 7 post-HoLEP and 0.3 post-MUS. The average morcellated prostate was 48 g, and surgical time was 68 min (52 for enucleation and 15 for morcellation). No complications were reported with MUS placement intraoperatively or postoperatively. MUS for persistent and bothersome SUI after HoLEP shows promise as a safe and effective surgical option.